A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease.

Keng-Thye Woo, Hui‐Lin Choong, Kok‐Seng Wong, Han-Kim Tan, Marjorie Foo, Fook-Chong Stephanie, Evan Jc Lee, Anantharaman Vathsala, Grace Sl Lee, Choong-Meng ChanPubMed 2013 · DOI

Abstract

This study in non-diabetic CKD patients showed that Combination therapy with Aliskiren and ARB was effective but was not safe as it was associated with a high prevalence of hyperkalaemia.
BibTeX
@inproceedings{woo2013retrospective,
  author = {Keng-Thye Woo and Hui‐Lin Choong and Kok‐Seng Wong and Han-Kim Tan and Marjorie Foo and Fook-Chong Stephanie and Evan Jc Lee and Anantharaman Vathsala and Grace Sl Lee and Choong-Meng Chan},
  title = {{A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease.}},
  booktitle = {PubMed},
  year = {2013},
  doi = {10.5527/wjn.v2.i4.129},
}

Loading related content...

Figure